NEUROCRINE BIOSCIENCES INC (NBIX) Common Stock, Shares, Outstanding 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Neurocrine Biosciences Inc quarterly Common Stock, Shares, Outstanding history and growth rate from 2010 to 2024.
  • Neurocrine Biosciences Inc Common Stock, Shares, Outstanding for the quarter ending March 31, 2024 was 101 M shares, a 3.18% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 101 M +3.1 M +3.18% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 98.7 M +2.2 M +2.28% Dec 31, 2023 10-Q 2024-05-01
Q3 2023 98.2 M +2.1 M +2.19% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 97.6 M +2 M +2.09% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 97.5 M +2 M +2.09% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 96.5 M +1.6 M +1.69% Dec 31, 2022 10-K 2024-02-09
Q3 2022 96.1 M +1.3 M +1.37% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 95.6 M +1 M +1.06% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 95.5 M +1 M +1.06% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 94.9 M +1.4 M +1.5% Dec 31, 2021 10-K 2023-02-09
Q3 2021 94.8 M +1.4 M +1.5% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 94.6 M +1.4 M +1.5% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 94.5 M +1.7 M +1.83% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 93.5 M +1.2 M +1.3% Dec 31, 2020 10-K 2022-02-11
Q3 2020 93.4 M +1.32 M +1.43% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 93.2 M +1.66 M +1.82% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 92.8 M +1.52 M +1.66% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 92.3 M +1.5 M +1.66% Dec 31, 2019 10-K 2021-02-05
Q3 2019 92.1 M +1.41 M +1.55% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 91.5 M +1.13 M +1.25% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 91.3 M +1.4 M +1.56% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 90.8 M +2 M +2.26% Dec 31, 2018 10-K 2020-02-07
Q3 2018 90.7 M +2.21 M +2.5% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 90.4 M +2.19 M +2.48% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 89.9 M +2.36 M +2.7% Mar 31, 2018 10-Q 2018-04-30
Q4 2017 88.8 M +1.91 M +2.2% Dec 31, 2017 10-K 2019-02-08
Q3 2017 88.5 M +1.6 M +1.84% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 88.2 M +1.47 M +1.69% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 87.5 M +947 K +1.09% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 86.9 M +621 K +0.72% Dec 31, 2016 10-K 2018-02-13
Q3 2016 86.9 M +982 K +1.14% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 86.8 M +1 M +1.17% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 86.6 M +1.2 M +1.41% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 86.3 M +9.8 M +12.8% Dec 31, 2015 10-K 2017-02-14
Q3 2015 85.9 M +9.89 M +13% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 85.8 M +9.83 M +13% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 85.4 M +9.51 M +12.5% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 76.5 M +9.11 M +13.5% Dec 31, 2014 10-K 2016-02-11
Q3 2014 76 M +8.65 M +12.8% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 75.9 M +8.92 M +13.3% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 75.9 M +9.15 M +13.7% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 67.4 M +904 K +1.36% Dec 31, 2013 10-K 2015-02-09
Q3 2013 67.3 M +962 K +1.45% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 67 M +678 K +1.02% Jun 30, 2013 10-Q 2013-07-26
Q1 2013 66.7 M +406 K +0.61% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 66.4 M +11.2 M +20.2% Dec 31, 2012 10-K 2014-02-11
Q3 2012 66.4 M +11.1 M +20.1% Sep 30, 2012 10-Q 2012-10-31
Q2 2012 66.3 M +11.1 M +20.1% Jun 30, 2012 10-Q 2012-07-31
Q1 2012 66.3 M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 55.3 M +381 K +0.69% Dec 31, 2011 10-K 2013-02-08
Q3 2011 55.3 M Sep 30, 2011 10-Q 2011-10-31
Q2 2011 55.2 M Jun 30, 2011 10-Q 2011-07-29
Q4 2010 54.9 M Dec 31, 2010 10-K 2012-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.